Document is current
Any future updates will be listed below
-
Authors
Lehnert, Martin http://orcid.org/0000-0003-2828-0430
Weber, Daniel G.
Taeger, Dirk
Raiko, Irina
Kollmeier, Jens
Stephan-Falkenau, Susann
Brüning, Thomas
Johnen, Georg
,
Brik, Alexander
Burek, Katarzyna
Dumont, Bettina
Casjens, Swaantje
Gleichenhagen, Jan
Hagemeyer, Olaf
Heimann, Heike
Kobek, Monika
Lechtenfeld, Claudia
Meier, Swetlana
Naumann, Simone
Nöllenheidt, Christoph
Pesch, Beate
Putzke, Simone
Rihs, Hans-Peter
Rozynek, Peter
Schonefeld, Sandra
Szafranski, Katja
Töpfer, Carmen
Wichert, Katharina
Wiethege, Thorsten
Zilch-Schöneweis, Sandra
-
Funding
Funding for this research was provided by:
Ruhr-Universität Bochum (IN-1214264)
- License Information
-
More Information
Article History
Received: 2 June 2020
Accepted: 15 July 2020
First Online: 29 July 2020
Ethics approval and consent to participate
: The study was designed according to the rules guarding patient privacy and with the approval from the ethics committee of the Ruhr University Bochum (Reference Number 3217–08). All participants provided written informed consent.
: Not applicable
: The IPA has supplied DLD Diagnostika GmbH with the antibodies to produce the Calretinin ELISA kits. In turn, the IPA has received Calretinin ELISA kits at a reduced price and may benefit from future sales of the kits. Otherwise, the individual authors declare no competing interests.
